Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Single-Center, Randomized, Open-label, Single Dose, Crossover Study in Korean Healthy Male Volunteers to Evaluate Pharmacokinetics of Lozanoc and Sporanox

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02493738
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:59.004113+00:00
Published At
2016-03-04T00:00:00+00:00
Record Updated At
2016-03-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Superficial Mycoses", "Dermatomycoses", "Candidiasis", "Histoplasmosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-03-04"
protocolSection.identificationModule.nctId
"NCT02493738"
protocolSection.identificationModule.officialTitle
"A Phase I Single-Center, Randomized, Open-label, Single Dose, Crossover Study in Korean Healthy Male Volunteers to Evaluate Pharmacokinetics of Lozanoc and Sporanox"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Superficial Mycoses (protocolSection.conditionsModule.conditions)
  • Dermatomycoses (protocolSection.conditionsModule.conditions)
  • Candidiasis (protocolSection.conditionsModule.conditions)
  • Histoplasmosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.